NCT04983550 2021-07-30Efficacy and Safety of SG001 Combined With PLD in Patients With Platinum-resistant Relapsed EOCCSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 2 Unknown126 enrolled